The Efficacy and Safety of Sanqi Qushi Granule in Patients with Idiopathic Membranous Nephropathy --Protocol of a Multicenter, Randomized Control Trial
Not Applicable
- Conditions
- Idiopathic Membranous Nephropathy (IMN)
- Registration Number
- ITMCTR2200006361
- Lead Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Age = 14 years old.
(2) Patients with determined diagnosis of IMN and need immunosuppressive therapy according to 2012 KDIGO guildlines;
(3) Patients agree to paticipate in this study and sign on the informed consent form.
Exclusion Criteria
(1) Secondary membranous nephropathy, i.e., caused by hepatitis B, SLE, malignancy, etc.;
(2) A known of contraindications and/or hypersensitivity to any ingredients of our research medications;
(3) Participating in another interventional clinical study.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method complete remission rate;partial remission rate;
- Secondary Outcome Measures
Name Time Method dampness syndrome score;concentration of PLA2R antibody;24-hour urine total protein;Urine Protein:Creatinine Ratio;estimated Glomerular Filtration Rate;side effect of immunology agents;endpoint events rate;